Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Global Arena Holding sells U.S. election services business to Easterly-backed GES Acquisition for $1.42 million cash, shares

Global Arena Holding sells U.S. election services business to Easterly-backed GES Acquisition for $1.42 million cash, shares

BitgetBitget2026/10/08 12:42

Global Arena Holding agreed to sell its U.S. absentee, mail-ballot, online election services business to GES Acquisition under an amended asset purchase agreement. Closing consideration includes assumed liabilities, USD 1,420,000 cash to subsidiary Global Election Services, and 1,841,761 GES Acquisition common shares. Easterly previously funded USD 3,196,000 to the sellers; accrued interest totaled USD 432,525 as of Oct. 2, 2026. Those previously funded amounts are set to be automatically forgiven at closing, eliminating ongoing repayment obligations to Easterly. Pre-closing steps include issuing 6,729,668 Series A convertible preferred shares to Easterly and an affiliate, priced at USD 0.00001 per share. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Global Arena Holding Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-046269), on October 08, 2026, and is solely responsible for the information contained therein.

  • Global Arena Holding agreed to sell its U.S. absentee, mail-ballot, online election services business to GES Acquisition under an amended asset purchase agreement.
  • Closing consideration includes assumed liabilities, USD 1,420,000 cash to subsidiary Global Election Services, and 1,841,761 GES Acquisition common shares.
  • Easterly previously funded USD 3,196,000 to the sellers; accrued interest totaled USD 432,525 as of Oct. 2, 2026.
  • Those previously funded amounts are set to be automatically forgiven at closing, eliminating ongoing repayment obligations to Easterly.
  • Pre-closing steps include issuing 6,729,668 Series A convertible preferred shares to Easterly and an affiliate, priced at USD 0.00001 per share.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Global Arena Holding Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-046269), on October 08, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss